News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Constellation Pharmaceuticals Appoints Kerry K. Reinertsen, Ph.D. as Company's Chief Business Officer



1/7/2010 9:05:46 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Constellation Pharmaceuticals, Inc. today announced that it has appointed Kerry K. Reinertsen, Ph.D. as the company’s Chief Business Officer. Dr. Reinertsen will manage Constellation’s corporate and business development activities, including the formation, implementation and management of research and development alliances to maximize value creation from its significant set of R&D assets.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES